According to the WHO, there are an estimated 253 million cases of vision impairment worldwide, and among them, almost 36 million people are blind. Major causes of this vision impairment include cataracts, refractive errors, glaucoma, etc. These eye-related disorders, primarily cataracts and refractive errors can lead to blindness if not treated promptly. There is a decrease in the prevalence of vision impairment due to increased awareness among the general population, socioeconomic development, and the increased availability of eye care services. However, the number of cases of vision impairment could triple due to population growth and aging.
Ocular surgery, commonly known as “eye surgery,” is a surgical procedure to treat these vision impairments. Ocular surgery is performed on the eye or the areas adjoining the eyes. Ocular surgical procedures are used to treat vision sharpness and clarity. Most of the market leaders are working on the development of current treatment methods. This development includes simplicity and less pain than conventional methods. Recently, new innovative techniques have been introduced in the ocular surgery device market.
The objective of this market research study titled “Ocular Surgery Devices Market: Growth, Future Prospects, and Competitive Analysis, 2017–2025” is to provide company executives, investors, industry participants, and developers with in-depth analysis to allow them to make decisions and strategic initiatives regarding scenarios in the ocular surgery devices market. This analysis report explains major trends in the global ocular surgery devices market and also provides an estimation of market size for the year 2016 and the forecast years (2017–2025).
This report studies the global ocular surgery devices market based on device types, procedures, end-users, and major geographical demarcations. Based on device type, the global ocular surgery devices market is categorized into glaucoma surgery devices, cataract surgery devices, refractive surgery devices, and vitreoretinal surgery devices. On the basis of procedures, the global ocular surgery devices market is segmented into cataract surgery, glaucoma surgery, vitrectomy surgery, and other ocular surgeries.
Other ocular surgeries consist of laser eye surgery, eye muscle surgery, corneal surgery, and oculoplastic surgery. The end users considered for the purpose of this study are hospitals, clinics, and others. The respective sections on such market segments comprise market size and forecasts based on the period 2015–2025 and their compounded annual growth rates for the forecast period 2017–2025.
Based on geography, the global ocular surgery devices market is segmented into five major regions considering major markets. North America includes the United States and Canada; Europe includes the United Kingdom, Germany, and the Rest of Europe; Asia Pacific includes China, Japan, and the Rest of Asia Pacific; Latin America includes Brazil, Mexico, and the Rest of Latin America; and the Middle East and Africa include the GCC and the Rest of Middle East and Africa.
The base year considered for the study is 2016, and the global ocular surgery devices market is forecasted for the period of 2017–2025. CAGRs are calculated for the forecast period, considering market drivers and restraints. The market size and forecast for these regional markets are further provided by device type, procedures, and end-users.
This analysis report also contains qualitative factors, including market dynamics (opportunities, drivers, and restraints), to provide a comprehensive understanding of the current and future trends in the global ocular surgery devices market. Tools for competition assessment, such as Porter’s five forces model, value chain analysis, the competitive landscape by key players, and market attractiveness analysis, are also provided in the study.
Furthermore, key players that at present have a prominent position in the global ocular surgery devices market are presented in the study with their basic market profiles. Major players in the global ocular surgery market that have been profiled in this study include A.R.C. Laser Gmbh, Accutome, Inc., Alcon, Inc., AqueSys, Inc., Bausch & Lomb, Inc., Carl Zeiss Meditech AG, Ellex Medical Lasers Ltd., Johnson & Johnson Vision Care Inc., Lumenis Ltd., Meridian AG, and Ziemer Ophthalmic Systems AG. NIDEK Co., Ltd., Rhein Medical, Inc., and STAAR Surgical Company
The ocular surgery devices market is studied in the following areas for the purposes of this study:
- Cataract surgery devices
- Glaucoma surgery devices
- Refractive surgery devices
- Vitreoretinal surgery devices
A cataract is a clouding of the eye lens that can impair vision and, if not treated, can lead to blindness. In cataract surgery, an incision is made in the eye, and the clouded eye lens is replaced by intraocular lenses (IOLs). These IOLs are of four types: monofocal, multifocal, toric, and accommodating devices. Ophthalmic viscosurgical devices (OVDs) are used alongside IOLs in cataract surgery to build and maintain space in the anterior chamber of the eye during the phacoemulsification procedure and implantation of an IOL. IOLs and OVDs together constitute the cataract surgery devices market.
Because of higher adoption and easy availability of these devices in developing countries, this segment leads the global ocular surgery devices market. Globally, around 20 million blind cases are due to cataracts, but these cases are disproportionately distributed, as 50% of them are in developing countries. Also, the number of cataract surgeries performed per million people per year (the cataract surgical rate) varies in developing countries. This segment is followed by glaucoma surgery devices, which include glaucoma drainage devices, implants, and lasers. Refractive surgery devices are comprised of ocular devices that are utilized to treat refractive errors of the eye, such as myopia, hyperopia, and astigmatism.
The most common procedure to correct refractive errors is LASIK (laser-assisted in situ keratomileuses). Vitreoretinal surgery devices include vitrectomy machines and packs, photocoagulation surgery devices, and illumination devices. Due to the improved availability of ocular surgery devices and their early adoption in major economies around the world as well as in developing nations, the global ocular surgery devices market is expected to expand at a considerable pace. Also, the incidence and prevalence of vision impairment disorders play a vital role in the expansion of the global ocular surgery devices market.
For the purpose of this study, the global ocular surgery devices market is studied for their application in the following usage areas:
Hospitals are the leading segment of the global ocular surgery devices market due to the affordability of expensive ocular devices and the presence of skilled surgeons. Ocular devices include lasers and other expensive equipment that is generally installed in hospitals. Additionally, conventional ocular surgeries, such as phacoemulsification, are only effective and safe when operated by skilled surgeons. The hospital segment is followed by clinics in terms of market value due to the low cost of procedures and quick turnaround times.
This segment is expected to expand at a greater pace due to the preference for these channels among patients. Although major and complex procedures are not available at ophthalmic clinics, some surgical procedures can be performed there. These procedures include refractive surgeries for myopia and hypermetropia. Therefore, it is expected that the growth of the clinic segment will be greater than the global market benchmark.
The ocular surgery devices market is studied for their procedure in the following areas for the purposes of this study:
- Cataract surgery
- Glaucoma surgery
- Vitrectomy surgery
- Other ocular surgeries
Based on the type of procedure, the global ocular surgery devices market is segmented into cataract surgery, glaucoma surgery, vitrectomy surgery, and other ocular surgeries. Other ocular surgeries consist of laser eye surgery, eye muscle surgery, corneal surgery, and oculoplastic surgery. According to the World Health Organization, cataract is the leading cause of blindness, accounting for nearly 51% of cases.
The introduction of a novel laser-assisted cataract surgery method has replaced the use of handmade incisions by the surgeon, thereby decreasing the chances of post-operative complications such as posterior vitreous detachment (PVD). As the global prevalence of cataracts is higher compared to other ophthalmic ailments, cataract surgery holds a major share of the ocular surgery devices market. The cataract surgery segment is followed by glaucoma surgery due to the high prevalence of glaucoma in developing countries.
According to the NCBI, approximately 11.2 million people in India aged 40 and older had glaucoma in 2010. Other ocular surgeries include laser eye surgery, eye muscle surgery, corneal surgery, and oculoplastic surgery. Eye muscle surgery (extraocular or strabismus surgery) is performed over one million times a year in America, making it the third most prevalent eye surgery. The main goal of eye muscle surgery is the correction of misalignment (crossed eyes). Among other ocular surgeries, eye muscle surgery leads the market.
As the population is rapidly aging, the incidence and prevalence of age-related disorders such as diabetes are bound to increase correspondingly, thus driving the growth in demand for ocular surgery devices. According to the International Diabetes Federation, in 2010, around 285 million people were affected by diabetes mellitus, which signifies a high risk of glaucoma and cataracts among these people. The adoption of new technologies and increases in healthcare expenditure among different geographies are other driving factors for the ocular surgery devices market.
Geographically, the ocular surgery devices market is cumulative for North America, Europe, Asia Pacific, the Middle East, Africa, and Latin America.
At present, North America leads the global ocular surgery devices market in terms of market value, followed by Europe. Better regulations, the presence of a sophisticated healthcare system, an evolved reimbursement scenario, and the high prevalence of cataract and glaucoma cases are the prime factors that favor the dominance of the North American market on the global front. In the United States, cataracts and glaucoma collectively affect around 27.1 million patients, and an estimated 2.4 million eye injuries occur each year in the Country.
Additionally, the prominence of the European market is mainly attributed to the higher prevalence of cataract and glaucoma cases, a significant preference for novel ocular surgery devices, and the dominant trend of adopting advanced treatment options in the healthcare systems. It is also projected that the Asia-Pacific region will witness the fastest market growth during the forecast period. This growth is anticipated based on improved awareness about the availability of novel devices, increasing patient preference for treatments with higher outcomes, higher disposable incomes, and rapidly increasing healthcare expenditure. According to the WHO, there are more than 2 million cases of unoperated cataracts in China alone.
Frequently Asked Question: